Gradient Dissent: Conversations on AI

Gradient Dissent: Conversations on AI


Accelerating drug discovery with AI: Insights from Isomorphic Labs

April 25, 2024

In this episode of Gradient Dissent, Isomorphic Labs Chief AI Officer Max Jaderberg, and Chief Technology Officer Sergei Yakneen join our host Lukas Biewald to discuss the advancements in biotech and drug discovery being unlocked with machine learning.Wit